Clinical Trial Update: A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tiragolumab plus atezolizumab versus atezolizumab monotherapy in PD-L1-positive metastatic/recurrent cervical cancer; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tecentriq (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-02-07